Mindpeak's mission is to enable personalised cancer treatment through AI tissue diagnostics Our partners are leading pathology and university labs. Our team consists of world-class industry experts in machine learning and company building. Mindpeak's Impact The demand for medical image analysis is growing rapidly but the number of cancer experts remains the same - this results in growing workloads per specialist. We help cancer experts meet this challenge. We build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Our tools assist cancer experts in providing reliable and reproducible diagnoses. This frees specialists from tedious, repetitive tasks …

9 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. A.I. - Deep Learning A.I. - Machine Learning

RNA Therapeutics We develop first-in-class RNA-based therapies, with lead programs in Head & Neck Squamous Cell Carcinoma (HNSCC) and Facioscalpulohumeral Muscular Dystrophy (FSHD). Our approach to drug design revolves around using genomic patient data to create highly tailored therapeutics – the right drug for the right patient. Our proprietary DREAmiRTM platform utilizes genomic and outcome data from thousands of patients to identify underlying genetic changes that cause their disease, and then creates a novel RNA therapeutic that can directly target and fix that genetic abnormality.

97 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology Data Analytics

Magnetic resonance and molecular imaging MR SOLUTIONS is a world leader in MRI technology (www.mrsolutions.com) We are a leading developer and manufacturer of the world’s first range of commercial, preclinical, cryogen-free, benchtop MRI systems (0.01T - 9.4T). Dry Magnets. We are the world’s largest, independent developer and manufacturer of MRI spectrometers for use by manufacturers of Clinical MRI systems and for upgrading any MRI scanner. MR SOLUTIONS, which is head quartered in the UK, is a world leader in the development and manufacture of MRI systems and components including; The world’s first range of commercial, ultra compact, cryogen free, 0.10T …

Type: SMB Activities: deeptech Technologies: New Materials

Husband to @lcrampsie | Father to @drizzlife and Scarlett | Sr. Director Industry Sales @InStepHealth the leader in #SmarterPOC and end-to-end Rx marketing!

Type: Startup Activities: martech Technologies: SaaS

We are Merck KGaA, Darmstadt, Germany and its global affiliates. We are a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a …

Type: Large company

Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with rare diseases—often with limited or no options—so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Founded in 2003, we maintain a highly collaborative culture where employees focus on how they can be successful and accomplish positive results …

Type: Large company

Break Boundaries. Ignite Change. IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines based on its T-win® platform. The T-win platform is based on a novel approach to cancer vaccines designed to activate T cells to target both tumor cells and the immune-suppressive cells in the tumor microenvironment. IO Biotech is advancing its lead cancer vaccine candidate, Cylembio, in clinical trials, and additional pipeline candidates through preclinical development. IO Biotech is headquartered in Copenhagen, Denmark and has US headquarters in New York, New York. IO Biotech has an experienced management team within the immune-oncology field …

34 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Everyone needs science. Science needs everyone. Since 1990, the Amgen Foundation has contributed over $500M to nonprofit organizations, including over $300M to science education. We are committed to advancing science literacy, inspiring the next generation of scientists and supporting communities where Amgen employees live and work.

Type: NGO, Think-tanks, Ed, & Culture Activities: edtech

Transforming Therapeutic Manufacturing Codexis is redefining what is possible in therapeutic development and manufacturing, leading the technology revolution with efficient, high-quality, and commercially proven solutions. The company’s manufacturing platforms consistently outperform legacy methods, enabling the development of therapeutic possibilities that were previously out of reach. With a proven track record, proprietary technology, and unrivalled scientific expertise, Codexis advances beyond conventional boundaries. More than a solutions provider, Codexis serves as a trusted long-term partner, committed to driving progress across complex therapeutic development and manufacturing. Biocatalysis, Directed Evolution, Enzyme Optimization, Biocatalysts, Enzyme Engineering, API manufacturing, Pharmaceutical manufacturing, RNA manufacturing, RNA detection, Oligo …

22 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center …

Type: Large company

The Deal Experts PharmaVentures is a global leader in life sciences dealmaking—spanning M&A, licensing, valuation and strategy. With 30+ years and 1,000+ clients supported transactions completed, we help clients originate, structure and execute deals that maximise value. Blending deep industry expertise, data-driven insight and a powerful global network, we turn opportunity into competitive advantage, consistently delivering outcomes for both buyers and sellers. For more details, visit https://www.pharmaventures.com Strategy, Mergers, Acquisitions, Licensing, Joint Ventures, Brokerage, Evaluation, Valuation, Commercial Intelligence, Due Diligence, Negotiation, Mediation, The Deal Experts, Transactions, Divestment, Deal Making Support, Strategic Planning, Market Access, Life Sciences, Pharma, and Biotech

Type: SMB Activities: fintech consulting Technologies: Data Analytics

Building Companies to Transform Patient Outcomes MPM BioImpact is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into cures for major diseases. With its world-class team and deep experience in scientific research, clinical development, and company-building, MPM BioImpact strives to power novel medical breakthroughs that transform patients’ lives. MPM BioImpact invests across the biotech landscape from early stage start-ups to public companies. Cancer Therapy, Disease Treatment, Funding companies to make a difference, Pharmaceuticals, Investment, Biotech, Venture Creation, and Therapeutics

Type: Incubators & VCs

From lab to life mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South …

95 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Powering innovation. Protecting health. We envision a world where our technology is amplified to touch the lives of billions, sparking transformation in global health. r&d, business partnerships, nanoparticle protein-based technology, matrix-m, adjuvant, and vaccines

Type: Large company

We're committed to a single purpose: Extending life’s moments for patients with rare diseases and their loved ones. PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for children and adults living with rare and serious disease. Orphan and Ultra-orphan Disorders and metabolic

Type: Large company

Chief Medical & Scientific Officer @irhythmtech. Co-founder https://t.co/gkWDOD6hia. Professor @Stanford @StanfordCDH. EP, scientist, trialist, builder. Views mine.

Type: SMB Activities: healthtech

Plexus Ventures is a prominent healthcare advisory boutique. Our team of professionals are located in markets all over the world – the United States, Europe, and the Asia-Pacific market, including China and Japan – enabling us to combine local knowledge with global reach. pharmaceutical, drug delivery, biotechnology, consumer & OTC, business development & consulting, out-licensing, in-licensing, divestments, acquisitions, global pharmaceutical market experts, marketing & sales, project management, biosimilars, medical device, and consultants

168 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

ABOUT Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on investing in life science companies that advance human health. Domain’s focused network, deep experience, and dependable reputation of this team have made it one of the top private-equity groups participating in healthcare investing. With $2.4 billion of capital under management, Domain invests in three major segments: pharmaceuticals, diagnostics, and medical devices. EXPERIENCE Domain has raised eight funds and has been involved in the formation of more than 250 portfolio companies. The partners of Domain have a total of close to 200 person-years of …

Type: Incubators & VCs

Award-winning PR & Advocacy firm | APAC | Integrated Communications | Healthcare, Tech, Development, Start-ups, Food & Nutrition | A @FINNPartners Company

Type: SMB Activities: martech consulting Technologies: Decarbonization

Biotherapies & Rare Disease CSL Behring, a Business Unit of CSL, is a global biotherapeutics leader driven by its promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease, and neurological disorders. The company’s products are also used in cardiac surgery, burn treatment and to prevent hemolytic disease of the newborn. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (ASX:CSL;USOTC:CSLLY), headquartered in Melbourne, Australia, employs more …

Type: Large company

ESPID's mission is to promote excellence in paediatric infectious diseases and child health. ESPID promotes the exchange of information among people who have special experience in the field of paediatric infectious diseases (by organizing regular scientific meetings, forming international study groups and networks, participation in advisory boards of other societies, organization of symposia at other international congresses, and through joint publications by members’ publications in the Pediatric Infectious Diseases Journal and other journals) ESPID supports the formation and function of independent units (e.g. sections, departments, divisions) in order to encourage progress in the field of infectious diseases in childhood. (as …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

CDC works 24/7 keeping America safe from health, safety and security threats, both foreign and domestic. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights it and supports communities and citizens to prevent it. CDC is the nation’s health protection agency - saving lives, protecting people from health threats, and saving money through prevention. For more information, please go to: http://www.cdc.gov/ Comment Policy: Please visit http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html to view CDC’s social media comment policy. Privacy Notice Regarding Third Party Websites: Privacy Notice: The Centers for Disease Control and Prevention …

Type: Public

Unlocking the broad potential of RNA medicines to transform human health We are a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Our RNA medicines platform, PRISM®, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Our toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing us with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Our diversified pipeline includes clinical programs in Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, Huntington’s disease, …

59 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

PA. Bringing Ingenuity to Life We believe in the power of ingenuity to build a positive human future. As strategies, technologies, and innovation collide, we create opportunity from complexity. Our diverse teams of experts combine innovative thinking and breakthrough technologies to progress further, faster. Our clients adapt and transform, and together we achieve enduring results. We are about 4,000 strategists, innovators, designers, consultants, digital experts, scientists, engineers, and technologists. And we have deep expertise in consumer and manufacturing, defence and security, energy and utilities, financial services, government and public services, health and life sciences, and transport. Our teams operate globally …

Type: Large company

At Arrowhead Pharmaceuticals we are breaking the mold of medicine. We are pushing the boundaries of therapeutic development and revolutionizing how we care for hard-to-treat illnesses. As a company we harness collaboration and innovation to rapidly advance drugs from discovery to the clinic. All applicants: Please be aware of employment scams using Arrowhead’s name and the names of Arrowhead’s employees. All job related Arrowhead communication should come from the domain @arrowheadpharma.com. Biotech, Drug Development, Pharmaceuticals, and RNAi

62 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Software that dominates. AI-powered automation for every decision. At Palantir, our software powers AI-driven decisions in critical government and commercial enterprises in the West, from the factory floors to the front lines. Our platforms feature advanced tools for data protection, governance, responsible use of AI, and civilian protection capabilities for defense applications. Dominate your most complex problems with Palantir. data integration, big data, enterprise software, data analytics, data protection, data engineering, artificial intelligence, and ai platform

Type: Large company

Providing national guidance and advice to improve health and social care. NICE balances the best care with value for money across the NHS and social care, to deliver for both individuals and society as a whole. We do this by: 🔹Providing rigorous, independent assessment of complex evidence to produce guidance and advice for health and social care practitioners. 🔹Developing recommendations that drive innovation into the hands of health and care professionals. 🔹Encouraging the uptake of best practice to improve outcomes for everyone. Health, Social Care, Public Health, and NHS

Type: Public Activities: healthtech

For the benefit of patients Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in the heart of the life sciences hub of Basel area, Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands: Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. In addition, we have several preclinical anti-infective assets in our portfolio. Basilea currently has about 150 employees and is listed on the SIX Swiss Exchange (SIX: …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Proven adherence solutions that drive outcomes HealthBeacon specializes in innovative adherence solutions for medication management. Our flagship product, the Injection Care Management System, improves medication adherence and delivers valuable data insights for patients, family members and clinicians alike. From supporting improved treatment outcomes to fostering a deeper understanding of patient needs, HealthBeacon empowers patients and transforms the landscape of healthcare delivery. In 2024, HealthBeacon was acquired by Hamilton Beach Health, a subsidiary of Hamilton Beach Brands Holding Co. (NYSE: HBB). This marked a significant step forward in our mission to enhance patient outcomes and strengthen our position in the healthcare …

19 similar entities Type: Startup Activities: healthtech Technologies: IoT

A life science venture capital firm building biopharma and device companies to address significant unmet medical needs RiverVest Venture Partners® is a leading venture capital firm building life science companies to address significant unmet needs of patients and deliver consistently strong returns to investors. With headquarters in St. Louis and offices in San Diego and Cleveland, RiverVest accesses forward-thinking research and clinical expertise at leading institutions across the country to found and fund biopharma and medical device companies. Entrepreneurs turn to RiverVest for the scientific, operational, financial, and investment expertise they need to achieve long-term success. RiverVest is committed to …

Type: Incubators & VCs

Devicare is a urology-focused pharma company for urogenital diseases. Devicare is a specialty biotech company dedicated to develop pathbreaking medical treatments in Urology combining the most recent scientific advances in nutritional therapy with digital technologies. Biotechnology, Medical devices , Digital Health , eHealth, Healthcare, and Digital Therapeutics

60 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Biotech company focusing on the discovery and development of novel targeted medicines to treat cancer and fibrosis Redx Pharma is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, highly targeted therapeutics for the treatment of cancer and fibrotic diseases Our team of scientists are based at our labs at Alderley Park, Cheshire, the UK’s largest single site life science campus. The team is made up of world class medicinal chemistry, biology and clinical capability with deep-rooted biotech and large pharma experience. Redx's lead asset, the selective ROCK2 inhibitor, zelasudil (RXC007), is in development for …

62 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

ONLY INTERESTED ON INVESTOR ROUND THE WORLD TO CONTACT ME AND TO BE MY FRIEND, BECAUSE HERE FOR IMPORTANT BUSINESS SURGEON DOCTOR, SPECIALIST IN ANY TYPE OF DISEASE, HUMBLE AND HONEST DOCTOR WHO IS READY TO FLY AROUND THE WORLD JUST TO CARE FOR HUMANITY

Type: Public

Seagen is now part of Pfizer! Together with our Pfizer colleagues, we will continue our mission of bringing life-saving treatments to people living with cancer. Our scientific leadership and world-leading antibody-drug conjugate (ADC) technology combined with the scale and strength of Pfizer's capabilities and expertise, will help position Pfizer at the forefront of innovation in cancer care. We are so proud of our employees for the work that has been done over the past 25 years to positively impact the cancer community. Check out the announcement https://lnkd.in/dfq7V-tw to join us in our excitement for the future. Seagen social media accounts, …

Type: Large company Activities: biotech deeptech Technologies: Synthetic Biology

Dragging Tomorrow Into Today. Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. For information on our Community Guidelines, please visit sarepta.com/community-guidelines. We want to share a reminder with all job seekers and candidates regarding the persistence of recruiting fraud. Please read a message about recruiting fraud and steps you can take to protect yourself here: https://www.sarepta.com/recruiting-fraud

Type: Large company

We develop breakthrough medicines for patients through precision small molecule design. Nimbus Therapeutics is a clinical-stage, structure-based drug discovery company developing novel small molecule medicines designed to act against well-validated but difficult-to-drug targets implicated in multiple human diseases. The company advances promising research based on a unique strategy that combines leading-edge computational technologies with a tailored array of machine learning-based predictive modeling approaches. Nimbus' pipeline includes a clinical-stage HPK1 inhibitor for the treatment of cancer (NCT05128487), as well as a diverse portfolio of preclinical programs focused on cancer, including a WRN program for MSI-H cancers, autoimmune conditions, and metabolic diseases. …

44 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at www.allogene.com/careers. oncology, cancer, biotechnology, immunotherapy, CAR T, and autoimmune

13 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or patientinfo@gene.com. Community Guidelines: 1. We want to foster …

Type: Large company

Sagard is an alternative asset management firm that invests in venture capital, private equity, private credit, real estate, and royalties. We invest in Europe through two private equity strategies. Sagard Midcap invests in middle-market business services, healthcare, food & consumer, and industrial sectors in Europe. Learn more at sagard.com/midcap Sagard NewGen supports entrepreneurs in the technology and healthcare industries to accelerate their growth projects in Europe and beyond. Learn more at sagard.com/newgen

Type: Incubators & VCs

City of Hope's mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research …

Type: Large company NGO, Think-tanks, Ed, & Culture Activities: healthtech deeptech

Fulfilling the promise of precision medicine through quality and innovation. Caris Life Sciences® (Caris) is the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has created the large-scale, clinico-genomic database and computing capability needed to analyze and unravel the molecular complexity of disease. This convergence of sequencing power, big data and AI technologies provides an unmatched platform to deliver the next-generation …

Type: Large company

The aim of thisismoney.co.uk is to win justice for its 3m-plus readers - and arm them with the best possible financial advice and information, empowering them to make the right choices. This is Money's editorial team has also built a reputation for fighting for readers'​ individual rights, intervening where necessary and winning dozens of individual victories.

Type: Media

Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive. Welcome To The Workplace With A Difference At Sage, we believe that life is more …

Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Innovating for patients and society Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, …

Type: Large company

Breaking through in the therapeutic areas of oncology and neurology. View our community guidelines: https://bit.ly/3dkY At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related …

Type: Large company

Transforming Cancer Care with AI Precision Medicine Ataraxis is an AI precision medicine company transforming cancer diagnostics and patient outcomes through the power of AI. We are addressing previously unsolvable problems in cancer prognosis and treatment selection through cutting-edge foundation models and multi-modal data. Our first clinically validated offering, Ataraxis Breast, is the world’s first AI-native prognostic/predictive test for breast cancer and provides greater accuracy than standard of care genomic assays. To learn more, visit ataraxis.ai.

Type: Startup Activities: healthtech deeptech Technologies: A.I.

Evoke MicroMass is now Inizio Evoke Drive, a global marketing agency that delivers full service creative capabilities to accelerate brands, businesses and patient experiences by delivering unmatched results for clients across every therapeutic area. Proudly part of Inizio Evoke, a global health marketing, communications, and transformation platform unlocking growth through data-driven insights and human centricity. We are purpose-built to make Health more humanTM. Follow Inizio Evoke to stay up-to-date with news, insights, and career opportunities from Inizio Evoke Drive. Marketing Agency, Behavioral Marketing, Digital Agency, CRM Agency, Communication Planning, RM Agency, Healthcare Relationship Marketing, Behavioral Research, Consulting, Creative, Full-Service, and …

2 similar entities Type: SMB Activities: martech Technologies: Data Analytics

Every immune system has a story to tell; the key is knowing how to listen. Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision. Working with drug developers, clinicians and academic researchers, we are applying these insights to develop products that will transform the way diseases -- such as cancer, autoimmune conditions, and infectious diseases -- are diagnosed and treated. For more information, please …

Type: Large company Activities: deeptech biotech Technologies: Synthetic Biology

Built on Trust, Toward Innovation Celltrion is a fully integrated biopharmaceutical company dedicated to delivering innovative and affordable medications to improve patients’ access to advanced therapies. Pioneering monoclonal antibody (mAb) biosimilars, built on a legacy of trust, we are advancing antibody-based biologics to address unmet medical needs. Our end-to-end capabilities - from R&D to distribution - ensure efficiency, quality, and innovation at every stage, bringing life-changing therapies to patients worldwide. Partnering with purpose, we are committed to driving customer intimacy to co-creating value at every touchpoint across the care journey. #BuiltonTrustTowardInnovation For guidelines: https://bit.ly/4jv2wf2 To transform possibility into a reality …

62 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Empowering Muscle Empowering Lives Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, we are developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Proud to be a San Francisco Business Times Best Place to Work in 2021 and 2022, a Great Place to Work-Certified company in 2022 and a part of Fortune's Best Workplaces in the Bay Area in …

44 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Strategic Consultancy - Senior Expertise - Impact Results Vane Percy & Roberts is a strategic consultancy specialising in communications, and outreach. With decades of senior-level experience, we provide tailored solutions that help businesses and organisations navigate complexity, enhance reputation, and drive meaningful results. What sets us apart? Expert-led strategy, a curated network of specialists, and a highly personalised approach. We ensure that you work directly with seasoned professionals who understand your challenges and align with your goals. Our expertise spans strategic consultancy, stakeholder engagement, brand positioning, thought leadership, and reputation management. Whether you’re looking to refine your strategy, amplify your …

154 similar entities Type: SMB Activities: consulting

3PL delivered by Alloga and ICS Alloga and ICS are leading third-party logistics (3PL) providers with a proven track record of delivering value to pharmaceutical companies. Alloga, with its Pan-European presence, and ICS, with its strong foothold in North America, offer a comprehensive suite of 3PL services tailored to the unique needs of the industry. Part of the Cencora family of companies Alloga and ICS are part of the Cencora family of companies. With collective resources spanning the entire healthcare ecosystem, we maximize the impact of your therapy from beginning to end — to create healthier futures for patients everywhere. …

Type: Large company

Fostering a collaborative community environment for the pharmaceutical and healthcare marketing ecosystem. More than 20 years ago, John Mack created The Pharma Marketing Network® at www.Pharma-Mkting.com and became a social media brand as "PharmaGuy"​. When John retired in 2018, R.J. Lewis was passed the baton and relaunched the site in March of 2019 with an impressive industry advisory board. The Pharma Marketing Network® (PMN) is now an open, collaborative community environment for the pharmaceutical and healthcare marketing ecosystem. The PMN is designed to understand the challenges and trends of today, while collaborating with industry professionals, thought leaders, and visionaries to …

Type: SMB Activities: martech

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global, diversified health care company that develops, manufactures and markets a range of products, primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees, and investors. Our global team comprises over 7,000 employees, united by our purpose to enrich people’s lives through our relentless drive to deliver better health outcomes. We develop, manufacture, and market health care products directly or indirectly in approximately …

Type: Large company

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and …

Type: Large company Activities: deeptech healthtech biotech

We are now Emota Meeting planners, Event production, Live events, Pharmaceutical meetings, Event communication, Incentives, Event management, Conferences, Sales conferences, Investigator meetings, Product launches, Creative development, and Exhibition services

Type: SMB Activities: healthtech

Evaluate provides trusted commercial intelligence and predictive analytics to the pharmaceutical industry Evaluate provides trusted commercial intelligence and forecasting models for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global biopharma market to drive better decisions. Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action. Evaluate Pharma - the trusted global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2030, company financials, pipelines, deals and more. Evaluate Omnium - provides a complete, dynamic …

Type: SMB Activities: consulting healthtech Technologies: Data Analytics

Changing lives with next generation peptide therapeutics At Zealand Pharma, we are a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals, bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. Ten drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market. Our current pipeline of internal product candidates focuses on obesity, chronic inflammation, and certain rare diseases. Our …

61 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Transforming the lives of patients through gene therapy uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases. aav, Huntington's disease, gene therapy, ALS, epilepsy, and Fabry disease

175 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

We humanize complexity to realize progress. We. is a global communications and integrated marketing agency that helps brands position themselves for success in an ever-changing world. We have been working for over four decades. at the intersection of technology, healthcare and people's needs - transforming innovative ideas into meaningful experiences that connect people. At a time when change is accelerating and expectations are rising, we use our expertise to help brands communicate through complexity. The goal: promote connections, understanding and progress. That's why we offer a range of solutions for different industries, target groups and stakeholders. Communications, Public Relations, Marketing, …

174 similar entities Type: SMB Activities: martech consulting Technologies: Data Analytics

Illness never sleeps, so neither can we #WeWontRest The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 41 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world. Twitter : @EFPIA Website : www.efpia.eu Pharmaceutical Industry

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech

Together we create sustainable growth - for the individual's health. Swelife wants to strengthen life science in Sweden and improve public health. Swelife works to increase cohesion and efficiency in the health and life science sectors in Sweden, in order to create growth and better public health. Swelife is a strategic innovation program that is financed by Vinnova and the project's partners. We want to make it possible for skills and resources to be used in the best way. We do this through national cooperation and coordination. We want to reduce the fragmentation within life science in Sweden. We work …

Type: Public Activities: healthtech biotech deeptech

Technologies to shape the future of health As of March 11, 2026, this account is no longer active. Please look for our content on the main NIH LinkedIn pages National Institutes of Health and NIH Innovates and follow along for the latest news and information from NIH!

Type: Public Activities: healthtech

We're a leading global eye health organization that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, we have a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Eye health, ophthalmic pharmaceuticals, ophthalmic surgical products, and contact lens …

Type: Large company

Alnylam is the leading RNAi therapeutics company. We're a fast-growing biopharma with a deep pipeline and global reach. SILENCE DISEASE. AMPLIFY LIFE.TM Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi …

Type: Large company

The mission of EMA is to foster scientific excellence in the evaluation and supervision of medicines in the EU. The European Medicines Agency (EMA) is a decentralised body of the European Union with headquarters in Amsterdam. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.

Type: Public

MediaAffairs entwickelt Wissen über Medienmärkte. Damit unterscheidet sich das Unternehmen wesentlich von konventionellen Anbietern aus dem Bereich der Medien(resonanz)analyse, die – auf gänzlich andere Art und Weise – Daten über Unternehmen, Personen, Themen usw. sammeln und als Informationen über das mediale Geschehen an ihre Kunden übermitteln. Auch MediaAffairs analysiert Medien, erarbeitet Statistiken über Präsenz, Themenführerschaft u.v.m. Darüber hinaus aber kennen wir die Medienmärkte, die wir im Auftrag unserer Kunden beschreiben. Daraus ergibt sich eine einzigartige Expertise unserer Mitarbeiter, mit der diese jede Information über das mediale Geschehen anreichern. Dies ist eine der wesentlichen Voraussetzungen, die uns für den professionellen Dialog …

Type: Media